Frequently Asked Questions Youll meet with a licensed medical professional who reviews your health goals and recommends the best IV therapy for your needs
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
In conditions like Long COVID and ME/CFS, the immune system is often stuck in a hyperactive, dysregulated state, constantly churning out inflammatory cytokines
Ethics declarations Ethics approval and consent to participate All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) of Huazhong University of Science and Technology (IACUC approval number: 2585)
Cell and tissue cultures Cells were cultured in Eagle's minimum essential medium supplemented with 10% (v/v) fetal bovine serum, 1% non-essential amino acids, 2 mM l-glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin at 37 C in a humidified atmosphere of 5% CO 2
& Newman, J